RU2019134554A3 - - Google Patents

Download PDF

Info

Publication number
RU2019134554A3
RU2019134554A3 RU2019134554A RU2019134554A RU2019134554A3 RU 2019134554 A3 RU2019134554 A3 RU 2019134554A3 RU 2019134554 A RU2019134554 A RU 2019134554A RU 2019134554 A RU2019134554 A RU 2019134554A RU 2019134554 A3 RU2019134554 A3 RU 2019134554A3
Authority
RU
Russia
Application number
RU2019134554A
Other versions
RU2751192C2 (ru
RU2019134554A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2019134554A publication Critical patent/RU2019134554A/ru
Publication of RU2019134554A3 publication Critical patent/RU2019134554A3/ru
Application granted granted Critical
Publication of RU2751192C2 publication Critical patent/RU2751192C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846Poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891Coated capsules; Multilayered drug free capsule shells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241Tumor Necrosis Factors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
RU2019134554A 2017-03-30 2018-04-03 Липосомальные композиции и содержащие их твердые пероральные лекарственные формы RU2751192C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17000536.7 2017-03-30
EP17000536 2017-03-30
PCT/EP2018/058464 WO2018178395A1 (en) 2017-03-30 2018-04-03 Liposomal compositions and solid oral dosage forms comprising the same

Publications (3)

Publication Number Publication Date
RU2019134554A RU2019134554A (ru) 2021-04-30
RU2019134554A3 true RU2019134554A3 (ru) 2021-04-30
RU2751192C2 RU2751192C2 (ru) 2021-07-12

Family

ID=58488775

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2019134554A RU2751192C2 (ru) 2017-03-30 2018-04-03 Липосомальные композиции и содержащие их твердые пероральные лекарственные формы

Country Status (8)

Country Link
US (1) US20200022914A1 (ru)
EP (1) EP3600253B1 (ru)
JP (1) JP2020515648A (ru)
CN (1) CN110520109A (ru)
ES (1) ES2909487T3 (ru)
RU (1) RU2751192C2 (ru)
WO (1) WO2018178395A1 (ru)
ZA (1) ZA201905763B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102112702B1 (ko) * 2019-12-19 2020-05-19 (주)슈퍼노바 바이오 표면 개질된 가스-생성 나노입자를 이용한 지방 분해용 조성물
EP4181881A1 (en) 2020-07-14 2023-05-24 Universität Heidelberg Oral pharmaceutical compositions comprising lipid conjugates
CN116370428A (zh) * 2023-04-28 2023-07-04 济南市中西医结合医院 一种布洛芬缓释片、制备方法及用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2130056B1 (es) * 1997-01-16 2000-02-01 Lipotec Sa Un nuevo preparado farmaceutico para mejorar la biodisponibilidad oral de drogas de dificil absorcion.
CN1218690C (zh) * 2002-09-17 2005-09-14 西安力邦医药科技有限责任公司 脂质体药物肠溶胶囊制剂
KR101590674B1 (ko) * 2010-06-14 2016-02-02 에프. 호프만-라 로슈 아게 세포-투과 펩티드 및 이의 용도
CN101966161B (zh) * 2010-09-06 2012-05-23 海南美兰史克制药有限公司 一种雷贝拉唑钠脂质体肠溶片
WO2013059617A1 (en) * 2011-10-21 2013-04-25 Ndsu Research Foundation Liposome compositions and methods of use
CN103417480A (zh) * 2013-07-11 2013-12-04 四川大学 一种靶向整合素受体的新型多肽修饰的肿瘤靶向脂质体
US20160106864A1 (en) * 2014-10-15 2016-04-21 Amorepacific Corporation Cell penetrating peptide introduced drug-delivery carrier comprising macromolecule
KR102441380B1 (ko) * 2014-10-15 2022-09-07 (주)아모레퍼시픽 거대분자를 포함하는 세포투과성 펩티드가 도입된 약물전달담체
EP3158992A1 (en) * 2015-10-21 2017-04-26 Universität Heidelberg Liposomes containing cell penetrating peptides and tetraetherlipids for the oral delivery of macromolecules

Also Published As

Publication number Publication date
ES2909487T3 (es) 2022-05-06
JP2020515648A (ja) 2020-05-28
WO2018178395A1 (en) 2018-10-04
ZA201905763B (en) 2021-09-29
RU2751192C2 (ru) 2021-07-12
EP3600253B1 (en) 2022-03-16
RU2019134554A (ru) 2021-04-30
EP3600253A1 (en) 2020-02-05
CN110520109A (zh) 2019-11-29
US20200022914A1 (en) 2020-01-23

Similar Documents

Publication Publication Date Title
BR122021024397A2 (ru)
BR122021023687A2 (ru)
BR122022003520A2 (ru)
BR122021000189A2 (ru)
BR122022025811B8 (ru)
RU2019134554A3 (ru)
BR112019008823A2 (ru)
BR112020006084A8 (ru)
BR122021014832A2 (ru)
BR202018014992U2 (ru)
BR112020008820A2 (ru)
BR102017023327A2 (ru)
BR202017021228U2 (ru)
BR202017020981U2 (ru)
BE2017C035I2 (ru)
BR202017017068U2 (ru)
BR202017016984U2 (ru)
BR202017016924U2 (ru)
BR102017015495A2 (ru)
BR102017015250A2 (ru)
BR102017014430A2 (ru)
BR202017012548U2 (ru)
BR202017011220U2 (ru)
BR202017010814U2 (ru)
BR202017010373U2 (ru)